FDA Reclassifies BPC 157 & TB 500 What the Research Shows #Shorts YouTube This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides FDA Peptide Reclassification 2026: What Researchers Want Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # Peptides Are Legal. Here's What Actually Matters Now. COP BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification